Sanofi/Aventis Merger Would Not Affect Exubera, Actonel Agreements, Sanofi Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi noted its track record with alliances and suggested that Aventis' partners could view the merger as a positive.